Nadia Agopyan's most recent trade in Marker Therapeutics Inc was a trade of 34,154 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | Nadia Agopyan | SVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 34,154 | 34,154 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Nadia Agopyan | VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) | |
| Marker Therapeutics Inc | Nadia Agopyan | VP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |